18F-FDG PET provides high-impact and powerful prognostic stratification in the staging of merkel cell carcinoma: A 15-year institutional experience

Journal of Nuclear Medicine

Volumn 54, Issue 8, 2013, Pages 1223-1229

  Siva, Shankar ^a,b   Byrne, Keelan ^b   Seel, Matthew ^c   Bressel, Mathias ^b   Jacobs, Daphne ^b   Callahan, Jason ^b   Laing, Joshua ^b   MacManus, Michael P ^b   Hicks, Rodney J ^a,b  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b PETER MACCALLUM CANCER CENTRE   (Australia)

^c Waikato Breast Cancer Care Centre   (New Zealand)

Author keywords

Merkel cell carcinoma; Positron emission tomography; Staging

Indexed keywords

CARBOPLATIN; ETOPOSIDE; FLUORODEOXYGLUCOSE F 18; DIAGNOSTIC AGENT;

ADULT; AGED; ARTICLE; CANCER MORTALITY; CANCER PROGNOSIS; CANCER STAGING; DISTANT FAILURE FREE SURVIVAL; FOLLOW UP; HUMAN; HUMAN TISSUE; LOCAL RECURRENCE FREE SURVIVAL; MAJOR CLINICAL STUDY; MERKEL CELL TUMOR; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PATIENT CARE PLANNING; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; PROSPECTIVE STUDY; RETROSPECTIVE STUDY; MIDDLE AGED; PATHOLOGY; PROGNOSIS; SCINTISCANNING; SKIN TUMOR; STAGING; SURVIVAL; TREATMENT FAILURE; VERY ELDERLY;

MERKEL CELL CARCINOMA; POSITRON EMISSION TOMOGRAPHY; STAGING;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, MERKEL CELL; FLUORODEOXYGLUCOSE F18; HUMANS; MIDDLE AGED; NEOPLASM STAGING; POSITRON-EMISSION TOMOGRAPHY; PROGNOSIS; RETROSPECTIVE STUDIES; SKIN NEOPLASMS; SURVIVAL ANALYSIS; TREATMENT FAILURE;

EID: 84881433120     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: 10.2967/jnumed.112.116814     Document Type: Article

References (19)

1. Toker C. Trabecular carcinoma of the skin. Arch Dermatol. 1972;105:107-110.
2. Howlader N, Noone AM, Krapcho M, et al. SEER Cancer Statistics Review, 1975-2009. Bethesda, MD: National Cancer Institute, November 2011.
3. Meeuwissen JA, Bourne R, Kearsley J. The importance of postoperative radiation therapy in the treatment of Merkel cell carcinoma. Int J Radiat Oncol Biol Phys. 1995;31:325-331.
4. Morrison WH, Peters LJ, Silva EG, Wendt CD, Ang KK, Goepfert H. The essential role of radiation therapy in securing locoregional control of Merkel cell carcinoma. Int J Radiat Oncol Biol Phys. 1990;19:583-591.
5. Veness MJ, Perera L, McCourt J, et al. Merkel cell carcinoma: improved outcome with adjuvant radiotherapy. ANZ J Surg. 2005;75:275-281.
6. Poulsen M. Merkel-cell carcinoma of the skin. Lancet Oncol. 2004;5:593-599.
7. Yao M, Smith RB, Hoffman HT, Funk GF, Graham MM, Buatti JM. Merkel cell carcinoma: two case reports focusing on the role of fluorodeoxyglucose positron emission tomography imaging in staging and surveillance. Am J Clin Oncol. 2005;28:205-210.
8. Wong CO, Pham AN, Dworkin HJ. F-18 FDG accumulation in an octreotide negative Merkel cell tumor. Clin Positron Imaging. 2000;3:71-73.
9. 18F-FDG PET-CT scanning for staging and management of Merkel cell carcinoma: a retrospective study of 15 patients. J Eur Acad Dermatol Venereol. 2011;25:1420-1427.
10. Peloschek P, Novotny C, Mueller-Mang C, et al. Diagnostic imaging in Merkel cell carcinoma: lessons to learn from 16 cases with correlation of sonography, CT, MR imaging and PET. Eur J Radiol. 2010;73:317-323.
11. 18F-FDG PET-CT scanning for staging and management of Merkel cell carcinoma: results from Westmead Hospital, Sydney, Australia. J Am Acad Dermatol. 2010;62:76-84.
12. 18F-FDG PET provides high-impact and powerful prognostic stratification in staging newly diagnosed non-small cell lung cancer. J Nucl Med. 2001;42:1596-1604.
13. Fowler JF. The linear-quadratic formula and progress in fractionated radiotherapy. Br J Radiol. 1989;62:679-694.
14. Poulsen M, Rischin D,Walpole E, et al. High-risk Merkel cell carcinoma of the skin treated with synchronous carboplatin/etoposide and radiation: a Trans-Tasman Radiation Oncology Group Study-TROG 96:07. J Clin Oncol. 2003;21:4371-4376.
15. Hawryluk EB, O'Regan KN, Sheehy N, et al. Positron emission tomography/ computed tomography imaging in Merkel cell carcinoma: a study of 270 scans in 97 patients at the Dana-Farber/Brigham and Women's Cancer Center. J Am Acad Dermatol. 2013;68:592-599.
16. Connell CA, Corry J, Milner AD, et al. Clinical impact of, and prognostic stratification by, F-18 FDG PET/CT in head and neck mucosal squamous cell carcinoma. Head Neck. 2007;29:986-995.
17. Golan H, Volkov O, Linchinsky O, Melloul M. FDG-PET imaging in Merkel cell carcinoma: value of head-to-toe scan. Nucl Med Rev Cent East Eur. 2005;8:135,136.
18. Iagaru A, Quon A, McDougall I, Gambhir S. Merkel cell carcinoma: is there a role for 2-deoxy-2-[f-18] fluoro-D-glucose-positron emission tomography/ computed tomography? Mol Imaging Biol. 2006;8:212-217.
19. Mojica P, Smith D, Ellenhorn JDI. Adjuvant radiation therapy is associated with improved survival in Merkel cell carcinoma of the skin. J Clin Oncol. 2007; 25:1043-1047.